CB
Consano Bio, Inc.
SEC filingBiotechnology · Burlington, MA
Amount raised$34.8Msold at filing
Total offering$48.9M$14M still open
Investors in the raise28count reported to the SEC
FiledMar 20, 2026first sale Mar 6, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Michael Vander PedeDirector
Bill Vander AbbingtonDirector
John Vander ConwayDirector
Joe Vander SchieslDirector
Jennifer SchmitkeExecutive Officer
Christopher Vander CentenoDirector
Doug Vander WeideDirector
Andrew HallExecutive Officer, Director
Jerome Vander AdamsDirector
Executive officers, directors and promoters as listed on the Form D.